<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63829">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01989637</url>
  </required_header>
  <id_info>
    <org_study_id>PKE STR</org_study_id>
    <nct_id>NCT01989637</nct_id>
  </id_info>
  <brief_title>Effect of Strawberries on Cardiovascular Disease Risk</brief_title>
  <official_title>Effects of a Freeze Dried Strawberry Powder on Postprandial Vascular Function and Blood Markers of Cardiovascular Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>California Strawberry Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Penn State University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is important to identify and evaluate foods, such as strawberries, that can improve
      established and emerging cardiovascular risk factors, such as postprandial lipid and
      glycemic responses, and vascular health. Postprandial derangements may affect multiple
      metabolic pathways that lead to increased arterial stiffness. Research has demonstrated the
      potential of strawberries to ameliorate postprandial responses to a high fat/high glucose
      meal. Further research is needed to demonstrate this effect in better controlled clinical
      studies and explore whether metabolic effects lead to improved arterial health.

      The investigators propose to examine the effects of adding 40 g of freeze-dried strawberry
      powder to a high fat/high glucose meal on postprandial cardiovascular risk factor including
      lipids, insulin, glucose, and arterial stiffness and central blood pressure. The
      investigators hypothesize that the bioactive components of strawberry powder will attenuate
      postprandial lipemic and glycemic responses, as well as improve measures of arterial health.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)</study_design>
  <primary_outcome>
    <measure>Change from baseline in postprandial triglycerides at 0.5, 1, 2, and 4 hours</measure>
    <time_frame>0.5, 1, 2, and 4 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in postprandial central blood pressure at 2 and 4 hours</measure>
    <time_frame>2 and 4 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in postprandial indices of arterial stiffness at 2 and 4 hours</measure>
    <time_frame>2 and 4 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial changes in insulin</measure>
    <time_frame>0, 0.5, 1, 2, and 4 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial changes in glucose</measure>
    <time_frame>0, 0.5, 1, 2, and 4 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial changes in markers of inflammation/oxidative stress</measure>
    <time_frame>0, 0.5, 1, 2, and 4 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Strawberry Meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>40 g freeze-dried strawberries included in test meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Meal</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control consisting of matched test meal with strawberry flavoring instead of freeze-dried strawberry powder</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Strawberry Meal</intervention_name>
    <arm_group_label>Strawberry Meal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control Meal</intervention_name>
    <arm_group_label>Control Meal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20-50 years of age

          -  LDL-C below 160 mg/dL

          -  Triglycerides below 350 mg/dL

          -  No stage II hypertension (BP below 160/100 mmHg)

          -  Not taking medication for elevated lipids, blood pressure, or glucose

        Exclusion Criteria:

          -  Allergies to strawberries

          -  Known intolerance to high fat meals

          -  History of cardiovascular disease, kidney disease, diabetes or inflammatory diseases
             such as GI disorders and arthritis

          -  Use of non-steroidal anti-inflammatory or immunosuppressant drugs

          -  Conditions requiring the use of steroids

          -  Use of medication or supplements for elevated lipids, blood pressure or glucose
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ann Skulas-Ray, PhD</last_name>
    <phone>814-863-8622</phone>
    <email>aus164@psu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Penn State University</name>
      <address>
        <city>University Park</city>
        <state>Pennsylvania</state>
        <zip>16801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Skulas-Ray, PhD</last_name>
      <phone>814-863-2923</phone>
      <email>aus164@psu.edu</email>
    </contact>
    <investigator>
      <last_name>Ann Skulas-Ray, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Penny Kris-Etherton, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Burdge GC, Calder PC. Plasma cytokine response during the postprandial period: a potential causal process in vascular disease? Br J Nutr. 2005 Jan;93(1):3-9. Review.</citation>
    <PMID>15705218</PMID>
  </reference>
  <reference>
    <citation>Jennings A, Welch AA, Fairweather-Tait SJ, Kay C, Minihane AM, Chowienczyk P, Jiang B, Cecelja M, Spector T, Macgregor A, Cassidy A. Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr. 2012 Oct;96(4):781-8. Epub 2012 Aug 22.</citation>
    <PMID>22914551</PMID>
  </reference>
  <reference>
    <citation>Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, Mattila P, Jula A. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008 Feb;87(2):323-31.</citation>
    <PMID>18258621</PMID>
  </reference>
  <reference>
    <citation>Basu A, Fu DX, Wilkinson M, Simmons B, Wu M, Betts NM, Du M, Lyons TJ. Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome. Nutr Res. 2010 Jul;30(7):462-9. doi: 10.1016/j.nutres.2010.06.016.</citation>
    <PMID>20797478</PMID>
  </reference>
  <reference>
    <citation>Basu A, Wilkinson M, Penugonda K, Simmons B, Betts NM, Lyons TJ. Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome: baseline and post intervention effects. Nutr J. 2009 Sep 28;8:43. doi: 10.1186/1475-2891-8-43.</citation>
    <PMID>19785767</PMID>
  </reference>
  <reference>
    <citation>Burton-Freeman B, Linares A, Hyson D, Kappagoda T. Strawberry modulates LDL oxidation and postprandial lipemia in response to high-fat meal in overweight hyperlipidemic men and women. J Am Coll Nutr. 2010 Feb;29(1):46-54.</citation>
    <PMID>20595645</PMID>
  </reference>
  <reference>
    <citation>Jenkins DJ, Nguyen TH, Kendall CW, Faulkner DA, Bashyam B, Kim IJ, Ireland C, Patel D, Vidgen E, Josse AR, Sesso HD, Burton-Freeman B, Josse RG, Leiter LA, Singer W. The effect of strawberries in a cholesterol-lowering dietary portfolio. Metabolism. 2008 Dec;57(12):1636-44. doi: 10.1016/j.metabol.2008.07.018.</citation>
    <PMID>19013285</PMID>
  </reference>
  <reference>
    <citation>Zunino SJ, Parelman MA, Freytag TL, Stephensen CB, Kelley DS, Mackey BE, Woodhouse LR, Bonnel EL. Effects of dietary strawberry powder on blood lipids and inflammatory markers in obese human subjects. Br J Nutr. 2012 Sep;108(5):900-9. doi: 10.1017/S0007114511006027. Epub 2011 Nov 9.</citation>
    <PMID>22068016</PMID>
  </reference>
  <reference>
    <citation>Skulas-Ray AC, Kris-Etherton PM, Teeter DL, Chen CY, Vanden Heuvel JP, West SG. A high antioxidant spice blend attenuates postprandial insulin and triglyceride responses and increases some plasma measures of antioxidant activity in healthy, overweight men. J Nutr. 2011 Aug;141(8):1451-7. doi: 10.3945/jn.111.138966. Epub 2011 Jun 22.</citation>
    <PMID>21697300</PMID>
  </reference>
  <reference>
    <citation>de la Garza AL, Milagro FI, Boque N, Campión J, Martínez JA. Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta Med. 2011 May;77(8):773-85. doi: 10.1055/s-0030-1270924. Epub 2011 Mar 16. Review.</citation>
    <PMID>21412692</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 20, 2013</lastchanged_date>
  <firstreceived_date>July 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Penn State University</investigator_affiliation>
    <investigator_full_name>Penny Kris-Etherton</investigator_full_name>
    <investigator_title>Penny Kris-Etherton</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
